EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Optical coherence tomography biomarkers for myopic choroidal neovascularization treated with anti‐vascular endothelial growth factor

Daniel Yu Lee iD, Po-Ying Wu, Shwu-Jiuan Sheu

The Kaohsiung Journal of Medical Sciences · 2023

DOI: 10.1002/kjm2.12669 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Kaohsiung Journal of Medical Sciences, 2023. Verfasst von Daniel Yu Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan. Hauptthemen laut MEDLINE: Myopia, Degenerative, Choroidal Neovascularization. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In recent years, optical coherence tomography (OCT) biomarkers for specific retinal diseases have been found to be associated with treatment outcome and disease recurrence. The main purposes of this study were to identify OCT biomarkers for myopic choroidal neovascularization (mCNV) treated with intravitreal injection of anti‐vascular endothelial growth factor (anti‐VEGF). OCT features in 43 eyes of 39 patients with mCNV treated with anti‐VEGF with at least 1 year of follow‐up were retrospectively analyzed. Eyes with subretinal hyperreflective material (SHM) in baseline spectral‐domain OCT (SD‐OCT) had significantly more visual improvement than eyes without SHM at month 6 ( p = 0.007) and had a trend of more visual improvement than eyes without SHM ( p = 0.058) at month 12. Eyes with subretinal fluid (SRF) at baseline had significantly more central retinal thickness (CRT) decrease than patients without SRF at month 6 and 12 ( p = 0.012 and 0.006 respectively). In univariate regression analysis, dome‐shaped macula (DSM), SRF in baseline OCT image and fuzzy border of mCNV when entering pro re nata (PRN) injection protocol tended to have higher risk of disease recurrence in 1 year (odds ratio: 14.86 ( p = 0.003), 3.75 ( p = 0.049) and 22.92 ( p < 0.001) respectively). However, they were not significant in multivariate regression analysis. OCT biomarkers at baseline could provide prognostic information for mCNV management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Myopia, DegenerativeChoroidal NeovascularizationHumansAngiogenesis InhibitorsEndothelial Growth FactorsVascular Endothelial Growth Factor ATomography, Optical CoherenceRetrospective StudiesVisual AcuityFluorescein AngiographyIntravitreal InjectionsBiomarkers

Stichwörter der Autor:innen

choroidal neovascularizationmyopiaoptical coherence tomography biomarkervascular endothelial growth factor

Substanzen

Angiogenesis InhibitorsEndothelial Growth FactorsVascular Endothelial Growth Factor ABiomarkers

Autor:innen und Institutionen

  • Department of Ophthalmology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
  • School of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.

ORCID-Profile: Daniel Yu Lee

Zitieren

APA

Lee, D. Y., Wu, P. Y., & Sheu, S. J. (2023). Optical coherence tomography biomarkers for myopic choroidal neovascularization treated with anti‐vascular endothelial growth factor. The Kaohsiung Journal of Medical Sciences. https://doi.org/10.1002/kjm2.12669

Vancouver

Lee DY, Wu PY, Sheu SJ. Optical coherence tomography biomarkers for myopic choroidal neovascularization treated with anti‐vascular endothelial growth factor. The Kaohsiung Journal of Medical Sciences. 2023. doi:10.1002/kjm2.12669

BibTeX
@article{Lee2023,
  author = {Lee, Daniel Yu and Wu, Po-Ying and Sheu, Shwu-Jiuan},
  title = {Optical coherence tomography biomarkers for myopic choroidal neovascularization treated with anti‐vascular endothelial growth factor},
  journal = {The Kaohsiung Journal of Medical Sciences},
  year = {2023},
  doi = {10.1002/kjm2.12669}
}
Kostenlos starten →